The Application dimension of Sleep Capnograph segmentation distinguishes three primary end‑use environments: Clinical sleep labs, Home sleep testing, and Research & development. In clinical sleep labs, capnographs are integrated with full‑scale polysomnography suites, driving the largest share of revenue due to high unit prices, recurring service contracts, and the need for continuous upgrades to meet accreditation standards. The home sleep testing segment, while lower‑priced per unit, contributes a growing proportion of the market as reimbursement policies expand and tele‑monitoring platforms mature, supporting a shift toward decentralized diagnostics. The research & development niche, though modest in absolute sales, exerts outsized influence on overall market size by spurring innovation, generating early‑adopter demand for advanced features such as real‑time waveform analytics and cloud‑based data integration. Collectively, these application categories account for the full market footprint, with their relative weight reflected in the accompanying pie‑chart, and illustrate how usage context directly shapes pricing dynamics and growth trajectories within the Sleep Capnograph market.